Office of Research Administration: Clinical Research Contracting
|
|
|
- Dorthy Brown
- 10 years ago
- Views:
Transcription
1 Office of Research Administration: Clinical Research Contracting Presented to: Research Administration Professionals Group Presented by: Patricia Travis and Mont Brownlee October 22,
2 Training Agenda Contracting Staff at Fells Point Types of Agreements Overview of Contracting Process for Agreements with Industry Sponsors Contracting Issues and Delays Resources and Questions October 22,
3 October 22,
4 October 22,
5 October 22,
6 October 22,
7 Clinical Research Contracting (a/k/a the Fell s Point Office ) Clinical Research Contracting Provide expertise to faculty and staff for clinical research agreements by reviewing academic, business, and legal issues. Negotiates non-disclosure agreements, contracts and other associated agreements with commercial sponsors. October 22,
8 What is Clinical Research? Clinical Research is all research that involves: Patients, or PHI (Protected Health Information), or clinical testing or procedures, or drug or device trials, or planning of clinical/lab services in support of clinical research. October 22,
9 Clinical Research Agreements Confidentiality Agreements (CDA or NDA) Clinical Trial Agreements (CTA) Funding, Supply or both Sponsor-initiated or Investigator-initiated Master Agreements and Work Orders Amendments (Supplements, extensions and modifications) Service Agreements (Lab services; Consulting) October 22,
10 Confidentiality Agreements (CDA s) Also called: Nondisclosure Agreements (NDA's) A MyRAP record is generated by ORA for each CDA No COEUS PD is required for CDA s What do I submit?: an editable version of the CDA to your Sponsored Project Specialist; Provide contact information for the Sponsor; and Identify the purpose and your timeline. October 22,
11 Clinical Trial Agreements (CTA's) Also called: Clinical Study Agreements (CSA's) A MyRAP record is generated by ORA for each CTA. Must be submitted via COEUS system with the following: Editable version of the contract document (preferably MS Word); Supplemental Information Sheet for Commercial Agreements (the "SIS") Proposed budget (draft is OK; does not need to be final); and Study protocol or Scope of Work (IRB application # may be listed). October 22,
12 Clinical Trial Agreements (CTA's) Once all materials are received, ORA will create a contract file and a contract reviewer can be assigned. Until ORA has a complete COEUS PD for a CTA, there is no contract file and your contract is not in the queue for review. ing CTA documents to ORA staff does not mean ORA has a contract file, and does not mean that a reviewer has been assigned. The Prospective Reimbursement Analysis (PRA), budget, IRB Review, and contract should be worked on simultaneously. October 22,
13 Clinical Trial Agreements (CTA's) ORA does not need an IRB approval to initiate contract review, but we need the approval in order to fully execute the contract. Contract negotiations and IRB review should proceed in parallel. A draft budget is needed to initiate contract review, but a final sponsor budget and internal budget will be needed to complete the contract negotiation. Contract and budget negotiations should proceed in parallel. October 22,
14 Study Startup Process Prospective Reimbursement Analysis Pre- Study Planning Budget Development Contracting Study approved for startup Study Accounts Established Institutional Review Board (IRB) October 22,
15 Contracting Lifecycle - ORA receives required documents logged in MyRAP - Assigned to ORA negotiator PI is notified - Initial Review; prepare redline draft for sponsor - Sponsor replies - Repeat as needed (elevate) - Resolve ancillary issues (budget; IRB; COI; etc) - Receive originals, review, obtain signatures (PDF v. hardcopy) October 22,
16 Computer Systems COEUS Proposal Development ( PD ) record includes key project data, Research Compliance Questionnaire, Investigator certifications and uploaded documents. MyRAP Launched Fall 2011; A MyRAP record is created for each agreement to track activity, pending issues, and communications. OCULUS/SAP Executed contract is scanned into OCULUS, which triggers Sponsored Shared Services that a new SAP account must be created. October 22,
17 Common Contracting Issues HIPAA & Informed Consent Issues Publication rights Indemnification & Subject Injury Intellectual Property (IP) Confidentiality Duty to Update (tied to JHM IRB s AAHRPP accreditation) Budget, payment schedule, and deposit details Biological Samples October 22,
18 Common causes for contracting delays - Incomplete Paperwork - Budget not resolved - CRO or Sponsor contact not authorized to negotiate - JHU Policy or Sponsor Responsibilities (General Counsel) - IRB Issue / Outside Interest management (COI) - Lack of parallel processing October 22,
19 Links to Contracting Resources: JHU SOM Office of Research Administration "How do I?" reference sheet for ORA Fells Point contracts: 26WhatcontrolstheroutingofAgreementswithCommercialSponsorstoORAFellsPointNALCOMMENTS.pdf ORA Information, Model Agreements and Policies: JHM Policy ORA.1 Sponsor Responsibilities: html Sponsored Projects Handbook: (Especially Appendix C & Appendix D for key overhead info) October 22,
20 THANKS! Any Questions? Patricia Travis, RN, Ph.D., CCRP Associate Director Clinical Research Office of Research Administration The Johns Hopkins School of Medicine 1629 Thames Street, Suite 200 Baltimore, Maryland Phone: Mont Brownlee, III, J.D. Associate Director Contracting Office of Research Administration The Johns Hopkins School of Medicine 1629 Thames Street, Suite 200 Baltimore, Maryland Phone: October 22,
21 Office of Research Administration Clinical Research Support Services 1629 S. Thames Street, Suite 200 Baltimore, Maryland /office /fax 1
22 Objectives Become familiar with our office staff, roles, and responsibilities. Understand a Prospective Reimbursement Analysis, how it can benefit your studies, and other documents related to the PRA process Gain tools and information to help in your budget development process 2
23 Office Organization Associate Director: Karen Roz, MS Sr. Clinical Research Coverage Analysts: Cindy Elliott Tracy McCracken RN BSN Lisa Wallace MT ASCP Clinical Research Coverage Analysts: Mario Adrien Genea Smith Linda Wilkins Leslie Wolf Dawn Young Erika Maden Gailunas Administrative Assistant TBN 3
24 Office of Research Administration Clinical Research Support Services Primary Function Prospective Reimbursement Analysis Multiple Secondary Functions Study Budgeting Initiate JHH Research Account through Patient Financial Services (PFS) Patient Financial Responsibility Sheet Clinical Research Insurance Clearance determination Etc. etc. etc 4
25 Prospective Reimbursement Analysis (PRA) Complex process Simultaneous with IRB review Contract negotiations Constantly changing Changes to regulations/coverages/care standards Changes in institutional processes 5
26 6
27 Prospective Reimbursement Analysis (PRA) PRA Initial Review Date Date Draft Completed Date Sent to PI for Review Final PRA Date IRB Approval Funding Awarded Author CRSS Analyst 7
28 Prospective Reimbursement Analysis (PRA) PRA Revision # and Date Original Application Changes in Research Study Identifying Information 8
29 Prospective Reimbursement Analysis (PRA) Issues Summary Protocol Informed Consent Contract Budget 9
30 Prospective Reimbursement Analysis (PRA) 10
31 Prospective Reimbursement Analysis (PRA) Does investigational item or service fall into a Medicare Benefit Category? Drugs, Biologics, Therapeutics Non-qualifying include: cosmetic surgeries, dental, etc. Does the study have therapeutic intent? Phase I studies Consent form benefit statement Does the study enroll patients with diagnosed diseases? Studies with only normal controls are non-qualifying Is the study a deemed trial? Federal oversight such as FDA monitored, Federally-funded consortium study, NIH funded. 11
32 Prospective Reimbursement Analysis (PRA) Investigational Item/Service Documents the investigational item/service Documents its FDA status (i.e. IND, IDE, exempt, etc) Whether or not CMS allows coverage 12
33 Prospective Reimbursement Analysis (PRA) 13
34 Prospective Reimbursement Analysis (PRA) Conventional Care Standard National Guideline Clearing House American College of Cardiology American College of Radiology National Comprehensive Cancer Network (NCCN) Items and Services Standard of Care Research Free Non-billable Additional Comments 14
35 Schema Prospective Reimbursement Analysis (PRA) Can be very simple or very complex Details participant timeline Details items/services described in protocol Details location where items/services are expected to be provided Delineates reimbursement analysis (i.e. Standard of Care vs. Research vs. Free vs. Non-billable) May include extensive footnotes 15
36 Prospective Reimbursement Analysis (PRA) Simple Schema 16
37 Prospective Reimbursement Analysis (PRA) Complex Schema 17
38 Prospective Reimbursement Analysis (PRA) Draft PRA EPIC form Draft Budget (if requested) Final PRA IRB Approval Funding Awarded Insurance Clearance status Patient Financial Responsibility Sheet EPIC Activation CRMS Further Study Actions Revised accordingly PRA used for charge adjudication is the one in effect at the time of participant consent 18
39 Prospective Reimbursement Analysis (PRA) Highlights Therapeutic Intent Phase I studies Consent form benefit statement Must use Patient Financial Responsibility Sheet CRMS Communicate, Communicate, Communicate 19
40 Prospective Reimbursement Analysis (PRA) Summary The PRA is the internal tool developed to document how each study meets the NCD criteria for billing routine costs to Medicare. A systematic review of clinical trial related documents to determine the billing status of items and services that are documented within the research protocol A method for ensuring that all the documents pertaining to a research protocol are consistent with each other 20
41 Budget Development and Negotiations 21
42 Budget Development Concurrent with PRA development How CRSS can help: Identify hidden costs Identify and document routine vs. research Provide completed budget template Negotiate with your sponsor 22
43 Budget Development Study Team must: Provide salary information Identify amount of effort for all personnel Identify cost amounts (i.e. cost of special labs, radiology procedures) Maintain timely communication with CRSS Process proposal through standard methods 23
44 Budget Negotiations Service offered by CRSS Benefits Maintain rapport with sponsor Removed from business aspect of research Institutional backing By request only Some PIs prefer to be hands-on with the negotiation process 24
45 Questions? Thank you 25
Office of Research Administration Clinical Research Support Services
Office of Research Administration Clinical Research Support Services 1629 S. Thames Street, Suite 200 Baltimore, Maryland 21213 410-502-6001/office 410-502-6004/fax [email protected] 1 Office Organization
Sponsored Projects Training: Submitting Contracts & Other Research Agreements to ORA
The Johns Hopkins University School of Medicine Office of Research Administration Sponsored Projects Training: Submitting Contracts & Other Research Agreements to ORA March/April 2013 We perform our work
Introduction to Clinical Research
Introduction to Clinical Research NCURA Region I Spring Meeting May 5, 2015 Agenda Introductions Brief History of Clinical Research Clinical Research in Context Clinical Research Compliance Clinical Research
SCHOOL OF MEDICINE OFFICE OF RESEARCH ADMINISTRATION
SCHOOL OF MEDICINE OFFICE OF RESEARCH ADMINISTRATION Step By Step Guide for: Coeus Proposal Development (Coeus PD) (in place of eis) for Paper (Hard) Copy and Electronic (non Grants.gov) submission Effective
Contents: Centers for Medicare/Medicaid (CMS) Clinical Trials Policy (CTP) Training. CMS CTP Background, Definitions and Requirements
Contents: CMS CTP Background, Definitions and Requirements Process Going Forward UW Medicine Process Reminders April 2009, Slide 1 Background: In 2000, Medicare issued a National Coverage Decision (NCD)
STANDARD OPERATING PROCEDURE FORMAL COVERAGE ANALYSIS
PURPOSE Establish a consistent comprehensive coverage analysis process that is well defined and performed on every clinical trial. UCSF REQUIREMENT Effective 6/1/2013, a formal coverage analysis must be
Coverage Analysis: The Cornerstone of Clinical Research Billing Presented by: Mary L. Veazie, CPA, MBA, CHC, CHRC Executive Director, Clinical
Coverage Analysis: The Cornerstone of Clinical Research Billing Presented by: Mary L. Veazie, CPA, MBA, CHC, CHRC Executive Director, Clinical Research Finance The University of Texas MD Anderson Cancer
Research Administration Retreat Research Administration 101. Tracy Wayman [email protected]
Research Administration Retreat Research Administration 101 Tracy Wayman [email protected] Sponsored Projects Shared Services (SPSS) Roles SPSS is responsible for setting up each grant s master data elements
Christopher Kratochvil, MD, Assistant Vice Chancellor for Clinical Research Deborah Vetter, MS, Director, Sponsored Programs Administration
Christopher Kratochvil, MD, Assistant Vice Chancellor for Clinical Research Deborah Vetter, MS, Director, Sponsored Programs Administration Clinical Research Center Learn-At-Lunch Series October 13, 2011
ROLE OF THE RESEARCH COORDINATOR Study Start-up Best Practices
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators ROLE OF THE RESEARCH COORDINATOR Study Start-up
Medicare Billing. Lisa R. Pitler, JD, MS, RN Assistant Vice Chancellor Research, Director of Clinical Trials Office University of Illinois at Chicago
Medicare Billing Lisa R. Pitler, JD, MS, RN Assistant Vice Chancellor Research, Director of Clinical Trials Office University of Illinois at Chicago May 14, 2015 Presentation Objectives Understand and
September 20, 2012. Kelly Willenberg, MBA, BSN, CHC, CHRC. Kelly Willenberg, LLC
September 20, 2012 Kelly Willenberg, MBA, BSN, CHC, CHRC 1 1 Understand the importance of research billing compliance and how that impacts the hospital and your practice Understand how billing can advance
CLINICAL RESEARCH ROLES CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES
CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES 1. Clinical Study Team Principal Investigator Co Principal Investigator (Co PI) Research Coordinator Study Monitor Data manage Sponsor Post Doctoral Scholar
Reliance Agreement for Institutions Utilizing Stony Brook University s Institutional Review Board(s)
Name of Organization Providing IRB Review: Stony Brook University ( SBU IRB ) Name of Institution Relying on the SBU IRB ( Institution ): Latest AAHRPP Accreditation Date (if applicable) OHRP Federal Wide
What Financial Administrators Must Know About Clinical Research at MSU
What Financial Administrators Must Know About Clinical Research at MSU Philip Reed, Interim Director CTSI & Director of BRIC, Clinical & Translational Sciences Institute Ann Smith, Operations Administrative
Research Coordinator - PI s who have research coordinators or secretarial support can designate individuals to manage their IRB protocols in Mentor.
Mentor Online IRB System IRB s require lots of documentation and managing this process can get to be a burden for both investigators and the IRB committee and administrator. The Mentor IRB system is designed
AAHRPP DOCUMENT # 84 UNIVERSITY OF ALABAMA HUMAN RESEARCH PROTECTIONS PROGRAM FORM: NOTIFICATION TO IRB OF EMERGENCY USE OF A TEST ARTICLE
1 AAHRPP DOCUMENT # 84 UNIVERSITY OF ALABAMA HUMAN RESEARCH PROTECTIONS PROGRAM FORM: NOTIFICATION TO IRB OF EMERGENCY USE OF A TEST ARTICLE Instructions Test Article means any drug, biological product,
Pre-Questions. Mastering Clinical Research July 29, 2015
Pre-Questions Mastering Clinical Research July 29, 2015 1. To be compliant with SOP 2.1 Obtaining Informed Consent for greater than minimal risk interventional clinical trial, which Licensed Professional
Fundamentals of Clinical Trial Financial Management
Fundamentals of Clinical Trial Financial Management Lindsey Spangler Michelle Smith COURSE OBJECTIVES Understand the life cycle of a clinical study from a financial perspective Understand the purpose of
Clinical Trials Budgeting and Billing
Clinical Trials Budgeting and Billing Presented by: Ellen N. Jamieson, MS, MBA Director, Grants Administration Alexandria Hui, BA Manager, Clinical Trial Financial Analyst Rules and Regulations Medicare
Clinical Trials Reporting Program (CTRP) and Clinicaltrials.gov (CT.gov) Helpful tips and guidance
Clinical Trials Reporting Program (CTRP) and Clinicaltrials.gov (CT.gov) Helpful tips and guidance Objectives NCI s Clinical Trials Reporting Program (CTRP) Overview CTRP What is it? CTRP is an NCI mandated
Children s Research Management System (CRMS) Version 3.0. Children s Hospital Colorado Research Institute Training Guide April 2015
Children s Research Management System (CRMS) Version 3.0 Children s Hospital Colorado Research Institute Training Guide April 2015 Table of Contents Operational Needs Assessment (ONA) 3 Visit Schedules
Medical Billing Human Research Studies Seminar Notes
Audits If a department learns that an external audit is going to be initiated, the Billing Compliance Department and Research Administration should be notified when the scope of the audit involves billing
U.S. Food and Drug Administration
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA s website for reference purposes only. It was current when produced, but is no longer maintained
Cheryl K. Bernstein RN, BSN, CCRC Director Bernstein Clinical Research Center, LLC Cincinnati, Ohio [email protected]
Cheryl K. Bernstein RN, BSN, CCRC Director Bernstein Clinical Research Center, LLC Cincinnati, Ohio [email protected] Identify and discuss the language used in reciprocal or crossed indemnification and
Orientation Manual for Clinical Research Coordinators
Orientation Manual for Clinical Research Coordinators Maine Medical Center Research Institute Page 1 of 19 Version 1 (2009) MAINE MEDICAL CENTER RESEARCH INSTITUTE Statement of Mission, Vision, Goals and
POLICY AND PROCEDURES OFFICE OF THE CENTER DIRECTOR. Table of Contents
POLICY AND PROCEDURES OFFICE OF THE CENTER DIRECTOR Tracking of Significant Safety issues in Marketed Drugs -- Use of the DARRTS Tracked Safety Issues Table of Contents PURPOSE...1 BACKGROUND...1 POLICY...2
Remote Monitoring of Clinical Trials and EMRs
Remote Monitoring of Clinical Trials and EMRs Sandra SAM Sather, MS, BSN, CCRA, CCRC Vice-President Clinical Pathways LLC [email protected] Lindsey Spangler, J.D. Associate Director,
When Research Fails: Integrating Research into EHR
When Research Fails: Integrating Research into EHR HCCA Research Compliance Conference Austin, Texas Session 301 June 3, 2013 Presenters Marti Arvin, JD, CHC F, CPC, CCEP F, CHRC, CHPC Chief Compliance
UW MEDICINE IDE/HDE DEVICE COVERAGE AND BILLING MAY, 2013
UW MEDICINE IDE/HDE DEVICE COVERAGE AND BILLING MAY, 2013 DEFINITIONS Investigational Device Exemption (IDE)- An approved IDE means that an IRB (and FDA for significant risk devices) has approved the sponsor
Clinical Trials (Post Award and CRMS) Dorothy Damron, Oncology Research Manager and CRMS Lead Scott Streibich, Clinical Research Revenue Cycle
Clinical Trials (Post Award and CRMS) Dorothy Damron, Oncology Research Manager and CRMS Lead Scott Streibich, Clinical Research Revenue Cycle 1 Objectives Key CRMS Functionality for Financial RAPs Centralizing
Review current regulatory climate Budget development Coverage analysis Charge reconciliation / 3 rd party billing Lessons learned
Meeting the Challenge of Compliant Clinical Research Billing Kathy Hammerhofer, BSN, RN Kelly Nottingham, MPH, CHES Objectives Review current regulatory climate Budget development Coverage analysis Charge
Applications are accepted on a rolling basis.
The University of Michigan Health System Peking University Health Science Center Joint Institute for Translational and Clinical Research Clinical Trial Grant Processes Purpose The University of Michigan
WHEN I WANT TO: I NEED TO SUBMIT: {for CIRB studies, see the specific FAQ}
IRB forms and materials to be submitted WHEN I WANT TO: I NEED TO SUBMIT: {for CIRB studies, see the specific FAQ} 1 2 Request a determination as to whether AHC is the appropriate IRB of record (i.e. is
2. For all clinical trials, the coverage analysis will also be audited to ensure compliance with the Medicare National Coverage Determination.
COMPLIANCE PROGRAM POLICY: Clinical Research Billing Audit Policy Effective Date: August 1, 2014 Last Updated: Page 1 of 8 I. POLICY All UC Irvine Health departments engaged in clinical research may be
Laurie Shaker-Irwin, Ph.D., M.S. Co-Leader, Regulatory Knowledge and Research Ethics UCLA Clinical and Translational Science Institute
Laurie Shaker-Irwin, Ph.D., M.S. Co-Leader, Regulatory Knowledge and Research Ethics UCLA Clinical and Translational Science Institute Understand the protocol completely Recognize institutional polices
INVESTIGATOR MANUAL. Table of Contents
Table of Contents HRP-910 001 10 Sep 2014 Page 1 of 7 What is the purpose of this manual?... 2 What is Human Research?... 2 What is the Human Research Protection Program?... 2 What training does my staff
The Ontario Cancer Research Ethics Board Overview
The Ontario Cancer Research Ethics Board Overview Research Ethics Research ethics review is vital to the advancement of ethically sound research. Before individuals can be enrolled in a research study,
Guidance for Industry Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions
Guidance for Industry Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions U.S. Department of Health and Human Services Food and Drug Administration Center for
The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial
The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial Clinical Research Operations & Regulatory Support (CRORS) Ann Glasse, RN, BSN, MBA Director-CRORS Objectives
A. HIPAA Privacy Authorizations and Exceptions for Use of Identifiable Protected Health Information
Protected Health Information and the JHSPH The Health Insurance Portability and Accountability Act (HIPAA) protects individually identifiable health information, or Protected Health Information ( PHI ),
Human Research Protection Program Good Clinical Practice Guidance for Investigators Investigator & Research Staff Responsibilities
This Guidance Document is to ensure that investigators and research personnel recognize their responsibilities associated with the conduct of human subject research by outlining their responsibilities,
Industry Clinical Trials: Budgeting and Expense Management
School of Medicine Alan P. Venook, MD Professor of Clinical Medicine Suzanne Sutton Director of Research Administration Industry Clinical Trials: Budgeting and Expense Management The UCSF Experience Industry
Mandatory Reporting of National Clinical Trial (NCT) Identifier Numbers on Medicare Claims Qs & As
Mandatory Reporting of National Clinical Trial (NCT) Identifier Numbers on Medicare Claims Qs & As Background Medicare may pay for items and services in clinical research studies under three policies:
Study Start-Up SS-204.01. STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV)
Study Start-Up SS-204.01 STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV) Approval: Nancy Paris, MS, FACHE President and CEO 08 March 2012 (Signature and Date) Approval: Frederick M. Schnell,
This policy applies to research administrators, investigators, research staff, Human Investigation Committee (HIC) members and HIC staff.
REVIEW BY AN EXTERNAL INSTITUTIONAL REVIEW BOARD 233 1 of 5 PURPOSE The purpose of this policy is to establish a procedure for requesting authorization for an approved, external (non-beaumont) institutional
Title: Department: Approved by:
Title: Department: Emergency Use of an Investigational Drug or Biological Product, or Unapproved Medical Device Human Research Affairs Policy Type: Partners System-wide Partners System-wide Template Partners
Guidance for IRBs, Clinical Investigators, and Sponsors. Considerations When Transferring Clinical Investigation Oversight to Another IRB
Guidance for IRBs, Clinical Investigators, and Sponsors Considerations When Transferring Clinical Investigation Oversight to Another IRB U.S. Department of Health and Human Services Food and Drug Administration
Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: [email protected]
SAMPLE CRA CV Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: [email protected] Education: Masters of Science, Healthcare Administration, Capital City University,
Principal Investigator and Sub Investigator Responsibilities
Principal Investigator and Sub Investigator Responsibilities I. Purpose To define the roles and responsibilities of Principal Investigators conducting research at GRU. II. Definition The term Principal
Comprehensive Study Documents List (Biomedical Studies)
Comprehensive Study Documents List (Biomedical Studies) Investigators conducting human subjects research must maintain study documents in adherence to federal and state regulations, USC policies, and good
Principal Investigator Responsibilities for Education and Social/Behavioral Researchers
Principal Investigator Responsibilities for Education and Social/Behavioral Researchers Introduction The purpose of this module is to provide a basic understanding of the responsibilities of the principal
NEW YORK STATE EXTERNAL APPEAL
NEW YORK STATE EXTERNAL APPEAL You have the right to appeal to the Department of Financial Services (DFS) when your insurer or HMO denies health care services as not medically necessary, experimental/investigational
Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health
Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health We are responsible for acquiring, analyzing, and protecting medical information vital to providing quality patient care HIM professionals ensure
Good Documentation Practices
Good Documentation Practices Clinical Research Operations & Regulatory Support Ann Glasse, RN, BSN, MBA Director, Regulatory Support Author: Johanna Stamates, RN, MA, CCRC, CHRC Objectives Recognize the
Roles & Responsibilities of the Sponsor
Roles & Responsibilities of the Sponsor Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Funding for clinical research comes from
PROTECTED HEALTH INFORMATION AND THE JHSPH
PROTECTED HEALTH INFORMATION AND THE JHSPH The Health Insurance Portability and Accountability Act (HIPAA) protects individually identifiable health information, or Protected Health Information ( PHI ),
Investigational Drugs: Investigational Drugs and Biologics
: I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place
Clinical Research Improvement in Systems and Processes - CRISP November 17, 2015
Clinical Research Improvement in Systems and Processes - CRISP November 17, 2015 The map of our journey - agenda October - November, 2015 Increased support and new roles Future State Process Project Steering
Research Administration Training Program for Existing Staff Johns Hopkins University
Research Administration Training Program for Existing Staff Johns Hopkins University 2014 Johns Hopkins University Page 1 Research Administration Training Program for Existing JHU Staff Introduction: Several
How to Run Clinical Trials in Private Practice
How to Run Clinical Trials in Private Practice Thomas M. Siler, MD Midwest Chest Consultants, PC Saint Charles, MO DISCLOSURE Dr. Siler has received research grants from GlaxoSmithKline, Forest, Boehringer
The Importance of Following the PROTOCOL in Clinical Trials
The Importance of Following the PROTOCOL in Clinical Trials Presentation Objectives: Upon completion of this presentation, participants will be able to: Describe the following terms: Protocol, Protocol
Managing Research Compliance Risks
Managing Research Compliance Risks James Moran, J.D., CPA Executive Director of Compliance, University of Pennsylvania School of Medicine Rick Rohrbach, MBA, CPA Senior Manager, Healthcare Consulting Practice
Yale Cancer Center Data and Safety Monitoring Committee Charter
Yale Cancer Center Data and Safety Monitoring Committee Charter Purpose/Mission The purpose of the Yale Cancer Center (YCC) Data and Safety Monitoring Committee (DSMC) is to provide ongoing data and safety
National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP)
National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP) Operating Manual Please check the CRN Website for the latest version. Version: 6.0 Status: Consultation in
Documentation of the Informed Consent Process. USC Office for the Protection of Research Subjects (OPRS)
Documentation of the Informed Consent Process USC Office for the Protection of Research Subjects (OPRS) Session Overview Highlights: Purpose of Informed Consent (IC) IC Process and Documentation Witness
UC Irvine Research Compliance Office
UC Irvine Research Compliance Office 1. Clinical Research Billing Compliance Risks 2. Benefits of a CRB Compliance Program 3. Implementation of a CRB Compliance Program 4. What is a Qualified protocol
The Monitoring Visit. Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis
The Monitoring Visit Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis Disclosure The information herein is not intended to
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:
Clinical Investigator Inspections and FDA-483 Observations
Clinical Investigator Inspections and FDA-483 Observations Nancy A. Bellamy, Investigator Bioresearch Specialist/ BIMO Coordinator FDA Detroit District Office October 2, 2013 Objectives Background on FDA
Essential Documents for the Conduct of a Clinical Trial. Debra Dykhuis Associate Director RSO
Essential Documents for the Conduct of a Clinical Trial Debra Dykhuis Associate Director RSO Introduction Rationale for choosing this topic AHC movement toward setting GCP (Good Clinical Practice) guidelines
MINUTES 430 th MEETING OF THE FACULTY SENATE 3:00 pm, Wednesday, May 7, 2014 School of Medicine Administration, Boardroom 103
MINUTES 430 th MEETING OF THE FACULTY SENATE 3:00 pm, Wednesday, May 7, 2014 School of Medicine Administration, Boardroom 103 PRESENT: Drs. Ahn, Ahuja, Bunz, Carroll, Crino, Gee, Gonzalez-Fernandez, Heitmiller,
Records and Clinical Trials
Integrating Electronic Health Records and Clinical Trials The Children s Hospital An Examination of Pragmatic Issues Affiliated with University of Colorado Health Sciences Center Denver, Colorado Michael
Clinical Trials: Questions and Answers
Clinical Trials: Questions and Answers Key Points Clinical trials are research studies that test how well new medical approaches work in people (see Question 1). Every clinical trial has a protocol, which
Clinical Trial Protocol Development. Developed by Center for Cancer Research, National Cancer Institute Endorsed by the CTN SIG Leadership Group
Clinical Trial Protocol Development Developed by Center for Cancer Research, National Cancer Institute Endorsed by the CTN SIG Leadership Group Objectives The clinical trial protocol is the heart of any
Vertex Investigator-Initiated Studies Program Overview
Vertex Investigator-Initiated Studies Program Overview Our Goal To support independent, investigator-initiated research designed to advance scientific knowledge of disease states, patient populations,
How to Develop a Clinical Study Site Budget
How to Develop a Clinical Study Site Budget Mary Fautsch Dale Klous White Paper 6/23/2011 Abstract Summary In today s dynamic environment, there is a need like never before for clinical data. In addition
2 Applicability: Effective Date: 1/15/2010 Revised: 8/13/2010, 9/10/10, 5/9/14
2 Applicability: Effective Date: 1/15/2010 Revised: 8/13/2010, 9/10/10, 5/9/14 NDSU research may involve the collaboration or assistance of other research institutions, schools, hospitals, clinics, private
Coverage Analysis. Purpose
Coverage Analysis Purpose The purpose of this policy is to provide a method for researchers to perform a Coverage Analysis (CA) for clinical research conducted at Mission Hospital, Inc., Memorial and St.
Use of Electronic Health Record Data in Clinical Investigations
Use of Electronic Health Record Data in Clinical Investigations Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding